Absorption peaks of groups. by Xinhui Luo (11880086)

“…Finally, considering all monomer surfactants’ abilities to reduce surface tension, decrease contact angles and promote dust settling in solutions, we selected five surfactants (AES, MES-30, AEO-9, CDEA and CHSB) for blending based on their excellent performance in tests. …”

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

Subjects:

The forest plots of pooled estimates of standardized mean differences of circulating apelin (A), apelin/HDL-c (B), apelin/LDL-c (C), apelin/triglycerides (D), and apelin/total chol... by Hamed Akbari (8119361)

Subjects:

Bacterial groups that significantly changed over time within the control group based on qPCR analysis. by Evangelia M. Stavroulaki (11840809)

The significant metabolites between adjacent groups. by Zhonglong Zhao (1546420)

Subjects:

KEGG enrichment pathway based on the significant metabolites detected in RSA and control group. by AiNing Wu (17692252)

“…<p>KEGG enrichment pathway based on the significant metabolites detected in RSA and control group.…”

Significant GO terms enriched based on the DEGs in control vs. noise groups. by Guangwei Ma (8503014)

“…<p>Significant GO terms enriched based on the DEGs in control vs. noise groups.…”

Significant GO terms enriched based on the DEGs in control vs. noise groups. by Guangwei Ma (8503014)

“…<p>Significant GO terms enriched based on the DEGs in control vs. noise groups.…”

Significant KEGG pathways enriched based on the DEGs in control vs. noise groups. by Guangwei Ma (8503014)

“…<p>Significant KEGG pathways enriched based on the DEGs in control vs. noise groups.…”

Plot of mean simulated power with 95 percentile (2.5 & 97.5%) for select DNAm differences. by Jacquelyn Y. Taylor (6386456)

Subjects:

Variability and correlations decrease during task states in human fMRI data. by Takuya Ito (57473)

“…<b>h)</b> We found that the average correlation for each brain region, decreased for each brain region during task state. …”

Response to NLC for 1 122 native plant species with significant null models. by Kaixuan Pan (11714457)

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects: